Keyphrases
Minocycline
100%
Early-onset Schizophrenia
100%
Double-blind Randomized Study
100%
Negative Symptoms
100%
Cognitive Symptoms
100%
Beneficial Effects
33%
Scale for the Assessment of Negative Symptoms
22%
Executive Function
22%
Cognitive Functioning
11%
Cognitive Assessment
11%
DSM-IV
11%
Neurotoxicity
11%
Mechanism of Action
11%
Adverse Events
11%
Schizophrenia
11%
Atypical Antipsychotics
11%
Antipsychotics
11%
Trial Registration
11%
Cognitive Deficits
11%
Schizophrenic Patients
11%
Background Current
11%
Tetracycline
11%
Randomized Placebo-controlled Trial
11%
Neurologic Disorders
11%
Functional Assessment
11%
Olanzapine
11%
Glutamatergic System
11%
Frontal Lobe
11%
Cognitive Planning
11%
Clozapine
11%
Nitric Oxide Inhibition
11%
Human Case
11%
Schizophrenia Treatment
11%
Working Memory
11%
Dopaminergic System
11%
Add-on Therapy
11%
Add-on Treatment
11%
Clinical Assessment
11%
Quetiapine
11%
Microglial Activation
11%
Nitric Oxide
11%
Inducible Nitric Oxide Synthase
11%
Clinical Global Impression Scale
11%
Equivalent Dose
11%
Risperidone
11%
Chlorpromazine
11%
Primary Outcome Measure
11%
Cognitive Shift
11%
Neuroscience
Minocycline
100%
Negative Syndrome
55%
Neurotoxicity
11%
Atypical Antipsychotic
11%
Placebo
11%
Frontal Lobe
11%
Cognitive Disorders
11%
Treatment of Schizophrenia
11%
Risperidone
11%
Chlorpromazine
11%
Tetracycline
11%
Nitric Oxide
11%
Nitric Oxide Synthase
11%
Clozapine
11%
Dopaminergic
11%
Olanzapine
11%
Quetiapine
11%
Cognitive Planning
11%
Executive Function
11%
Working Memory
11%
Pharmacology, Toxicology and Pharmaceutical Science
Minocycline
100%
Negative Syndrome
55%
Adverse Event
11%
DSM-IV
11%
Placebo
11%
Atypical Antipsychotics
11%
Neurotoxicity
11%
Risperidone
11%
Tetracycline
11%
Clozapine
11%
Chlorpromazine
11%
Nitric Oxide
11%
Nitric Oxide Synthase
11%
Cognitive Defect
11%
Neurologic Disease
11%
Olanzapine
11%
Quetiapine
11%
Dopamine Receptor Stimulating Agent
11%
Add on Therapy
11%
Psychology
Schizophrenia
100%
Cognitive Functioning
20%
Cognitive Deficit
20%
Working Memory
20%
Dopaminergic System
20%
Olanzapine
20%
Cognitive Planning
20%
Functional Assessment
20%
Treatment of Schizophrenia
20%
Chlorpromazine
20%
Executive Function
20%